<DOC>
	<DOCNO>NCT01369576</DOCNO>
	<brief_summary>The clinical population target newly diagnose patient polysomnographically diagnose OSA currently take hypnotic concomitantly diagnose insomnia . Outpatients also judge capable follow study procedure ( consent , timeline , visit , questionnaire ) concurrent disease view investigator interfere participation trial completion include . Approximately 160 subject recruit ( 80 per treatment arm ) recent trial eszopiclone . This size expect able discern important difference 80 minute per night . In current clinical population newly prescribe CPAP Mount Sinai Hospital , average compliance 4 week initiation nCPAP 4:01 ( SD 2:59 ) hour per night . To able discern difference least 1 hour ( 60 minute ) usage per night , include entirely non-adherent patient use treatment 'zero hour ' user , would require randomization 264 patient ( 132 per group ) . Our hypothesis study initial titration CPAP treatment OSA may improve initial prescription common hypnotic , zopiclone . To answer question intend recruit 264 consecutive consent subject OSA confirm physician ( ABSM respirologist extensive sleep medicine experience ) supportive polysomnography result willing initiate long-term CPAP treatment .</brief_summary>
	<brief_title>Effect Zopiclone Compliance With Continuous Positive Airway Pressure Obstructive Sleep Apnea</brief_title>
	<detailed_description>Background : Obstructive sleep apnea ( OSA ) common sleep breathing disorder associate serious complication . Continuous positive airway pressure ( CPAP ) treatment choice patient use real world limit low patient adherence may result sub-optimal outcome patient . A single hypnotic low risk adverse effect cost-effective intervention augment currently low adherence CPAP , especially prescribe limited time . The hypnotic generic zopiclone 3.75-7.5 mg bedtime 14 dos . The clinical population target newly expert physician-diagnosed patient polysomnographically support OSA currently take hypnotic concomitantly diagnose insomnia . Outpatients also judge capable follow study procedure ( consent , timeline , visit , questionnaire ) concurrent disease view investigator interfere participation trial completion include .</detailed_description>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Zopiclone</mesh_term>
	<criteria>MD diagnosis obstructive sleep apnea No previous use CPAP No concurrent use hypnotic medication Fatal comorbidities ( i.e. , life expectancy le 6 month ) Contraindications CPAP use Pregnancy Liver Failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>